Montag & Associates’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Hold
1,200
– – 0.01% 390
2026
Q1
$265K Hold
1,200
– – 0.01% 381
2025
Q4
$304K Hold
1,200
– – 0.01% 356
2025
Q3
$297K Hold
1,200
– – 0.01% 358
2025
Q2
$288K Hold
1,200
– – 0.01% 360
2025
Q1
$272K Hold
1,200
– – 0.01% 381
2024
Q4
$247K Hold
1,200
– – 0.01% 401
2024
Q3
$291K Hold
1,200
– – 0.01% 380
2024
Q2
$263K Hold
1,200
– – 0.01% 376
2024
Q1
$270K Hold
1,200
– – 0.01% 380
2023
Q4
$264K Hold
1,200
– – 0.01% 369
2023
Q3
$263K Hold
1,200
– – 0.02% 353
2023
Q2
$270K Hold
1,200
– – 0.02% 358
2023
Q1
$230K Hold
1,200
– – 0.02% 364
2022
Q4
$222K Hold
1,200
– – 0.01% 350
2022
Q3
$200K Hold
1,200
– – 0.01% 352
2022
Q2
$247K Hold
1,200
– – 0.02% 337
2022
Q1
$290K Hold
1,200
– – 0.02% 349
2021
Q4
$292K Hold
1,200
– – 0.01% 351
2021
Q3
$245K Hold
1,200
– – 0.01% 361
2021
Q2
$248K Hold
1,200
– – 0.01% 363
2021
Q1
$229K Hold
1,200
– – 0.01% 365
2020
Q4
$227K Buy
+1,200
New +$224K 0.01% 346

Other funds holding STE

Montag & Associates's STE Position: Q2 2026 in Review

Montag & Associates held its Steris (STE) position steady in Q2 2026 at 1,200 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #390.

Montag & Associates first reported a position in STE in Q4 2020 and has held it in 23 quarters since. The position peaked at $304K in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Montag & Associates held 1,200 shares of Steris worth $253K as of Q2 2026.
  • Montag & Associates left its Steris share count unchanged in Q2 2026.
  • Steris made up 0.01% of Montag & Associates's portfolio in Q2 2026, its #390 holding.
  • Montag & Associates first reported a position in Steris in Q4 2020 and has held it in 23 quarters since.
  • Montag & Associates's Steris position peaked at $304K in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.